Prestwick Original Molecules Library: innovative and exclusive screening compounds
This Library is made of a collection of 344 original exclusive compounds representing your premium resource for novel screening hit discovery. All molecules have been designed to ensure optimal chemical diversity and are suitable for various structural modifications yielding analogs with promising IP positions. The library combines promising drug-like properties as well as favorableADME-Tox properties with high potential therapeutic score.
A unique and diversified library of original & exclusive drug-like compounds
An original collection of 344 exclusive compounds
Designed while considering drug-like properties
Optimal diversity, suitable for multiple chemical modifications
Promising IP positions
Small drug-like molecules (mean MW: 395)
Innovative compounds with favorable lead-likeproperties (Oprea) and as well as drug-like properties (Lipinski)
Using a structure-based approach (pharmacophore-based virtual screening), each compound was investigated for its potential interactions with protein targets ranging from CNS to oncology, cardiovascular and antimicrobial fields. Target prediction shows that the selected Prestwick Original Molecules might be active in different therapeutic areas during development processes.